| Sep'13 | Jun'13 | Mar'13 | Dec'12 | Sep'12 | Jun'12 | Mar'12 | Dec'11 | Sep'11 | Jun'11 | Mar'11 | Dec'10 | Sep'10 | Jun'10 | Mar'10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statement [Table] | ||||||||||||||
Statement [Line Items] | ||||||||||||||
Cash flows from financing activities | ||||||||||||||
Net cash provided by/(used) in operating activities | ||||||||||||||
- | - | 0 | - | - | - | 2,623,000 | 2,550,000 | 2,448,000 | 1,552,000 | 1,387,000 | 1,038,000 | 0 | 0 | 0 |
Net income/(loss) | ||||||||||||||
-1,942,000 | -1,745,000 | 671,000 | 848,000 | 1,168,000 | 1,466,000 | 1,629,000 | 1,475,000 | 1,268,000 | 862,000 | 228,000 | 166,000 | 0 | 0 | 0 |
Loss/(profit) on sale of assets, realization of loans, indirect taxes and other | ||||||||||||||
394,000 | 339,000 | 73,000 | 35,000 | -1,000 | 20,000 | 13,000 | 27,000 | 4,000 | 17,000 | 16,000 | 22,000 | 0 | 0 | 0 |
Depreciation, depletion and amortization | ||||||||||||||
788,000 | 814,000 | 811,000 | 794,000 | 794,000 | 787,000 | 786,000 | 789,000 | 789,000 | 771,000 | 737,000 | 720,000 | 0 | 0 | 0 |
Impairment of assets | ||||||||||||||
- | - | - | - | - | - | - | 17,000 | 73,000 | 83,000 | 83,000 | 91,000 | 0 | 0 | 0 |
Deferred taxation | ||||||||||||||
-427,000 | -462,000 | -161,000 | -74,000 | 252,000 | 268,000 | 332,000 | 299,000 | 223,000 | 325,000 | 191,000 | 138,000 | 0 | 0 | 0 |
Movement in non-hedge derivatives and bonds | ||||||||||||||
-441,000 | -427,000 | -296,000 | -265,000 | -171,000 | -196,000 | -279,000 | -196,000 | 874,000 | 2,096,000 | 2,668,000 | 2,544,000 | 0 | 0 | 0 |
Movement in non-hedge derivatives and bonds | ||||||||||||||
- | - | - | - | - | - | - | -196,000 | 874,000 | 2,096,000 | 2,668,000 | 2,544,000 | 0 | 0 | 0 |
Equity loss/(income) in associates | ||||||||||||||
-211,000 | -236,000 | -34,000 | -23,000 | 24,000 | 50,000 | 60,000 | 59,000 | 45,000 | 29,000 | 24,000 | 40,000 | 0 | 0 | 0 |
Dividends received from associates | ||||||||||||||
47,000 | 51,000 | 72,000 | 79,000 | 88,000 | 108,000 | 101,000 | 111,000 | 117,000 | 108,000 | 157,000 | 143,000 | 0 | 0 | 0 |
Other non cash items | ||||||||||||||
-23,000 | -28,000 | -42,000 | -53,000 | -56,000 | -52,000 | -41,000 | -29,000 | 0 | 0 | 0 | - | - | - | - |
Other non cash items | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net (decrease)/increase in provision for environmental rehabilitation, pension and other post-retirement medical benefits | ||||||||||||||
-18,000 | -12,000 | 16,000 | 35,000 | 162,000 | 157,000 | 204,000 | 189,000 | 156,000 | 166,000 | 129,000 | 131,000 | 0 | 0 | 0 |
Receivables | ||||||||||||||
-107,000 | 13,000 | 45,000 | 117,000 | 191,000 | 25,000 | 3,000 | 13,000 | 63,000 | 171,000 | 173,000 | 153,000 | 0 | 0 | 0 |
Inventories | ||||||||||||||
244,000 | 299,000 | 323,000 | 324,000 | 325,000 | 254,000 | 268,000 | 244,000 | 208,000 | 248,000 | 190,000 | 215,000 | 0 | 0 | 0 |
Accounts payable and other current liabilities | ||||||||||||||
-35,000 | 30,000 | 155,000 | 246,000 | 72,000 | 110,000 | 111,000 | 126,000 | 281,000 | 129,000 | 130,000 | 54,000 | 0 | 0 | 0 |
Net cash (used)/generated in investing activities | ||||||||||||||
- | 0 | 0 | - | - | -1,844,000 | -1,715,000 | -1,603,000 | -1,722,000 | -2,201,000 | -2,040,000 | -1,887,000 | 0 | 0 | 0 |
Available for sale investments acquired | ||||||||||||||
6,000 | 9,000 | 9,000 | 6,000 | 6,000 | 39,000 | 44,000 | 47,000 | 0 | 0 | 0 | - | - | - | - |
Held to maturity investments acquired | ||||||||||||||
84,000 | 82,000 | 81,000 | 91,000 | 86,000 | 108,000 | 111,000 | 100,000 | 0 | 0 | 0 | - | - | - | - |
Contributions to associates and equity accounted joint ventures | ||||||||||||||
526,000 | 510,000 | 452,000 | 347,000 | 242,000 | 169,000 | 128,000 | 107,000 | 0 | 0 | 0 | - | - | - | - |
Increase in non-current investments | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Additions to property, plant and equipment | ||||||||||||||
1,633,000 | 1,795,000 | 1,794,000 | 1,758,000 | 1,589,000 | 1,523,000 | 1,471,000 | 1,393,000 | 0 | 0 | 0 | - | - | - | - |
Interest capitalized and paid | ||||||||||||||
9,000 | 15,000 | 14,000 | 12,000 | 8,000 | 4,000 | 2,000 | 0 | 0 | 0 | 0 | - | - | - | - |
Expenditure on intangible assets | ||||||||||||||
77,000 | 84,000 | 85,000 | 79,000 | 62,000 | 44,000 | 23,000 | 16,000 | 0 | 0 | 0 | - | - | - | - |
Additions to property, plant and equipment | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Proceeds on sale of mining assets | ||||||||||||||
8,000 | 10,000 | 4,000 | 5,000 | 11,000 | 13,000 | 18,000 | 19,000 | 14,000 | 74,000 | 69,000 | 69,000 | 0 | 0 | 0 |
Proceeds on sale of available for sale investments | ||||||||||||||
- | - | - | - | - | - | - | 2,000 | 0 | 0 | 0 | - | - | - | - |
Proceeds on redemption of held to maturity investments | ||||||||||||||
76,000 | 79,000 | 77,000 | 86,000 | 160,000 | 104,000 | 111,000 | 89,000 | 0 | 0 | 0 | - | - | - | - |
Proceeds on sale of investments | ||||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | - | 0 | 0 | 0 |
Proceeds on disposal of associates and equity accounted joint ventures | ||||||||||||||
6,000 | 6,000 | 5,000 | 20,000 | 20,000 | 20,000 | 20,000 | 0 | 1,000 | 0 | 0 | 1,000 | 0 | 0 | 0 |
Cash inflows from derivatives purchased | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
Proceeds on disposal of subsidiary | ||||||||||||||
8,000 | 7,000 | 7,000 | 6,000 | 0 | 0 | 0 | 9,000 | 9,000 | 9,000 | 9,000 | 0 | 0 | 0 | 0 |
Loans advanced to associates and equity accounted joint ventures | ||||||||||||||
27,000 | 25,000 | 50,000 | 65,000 | 76,000 | 86,000 | 40,000 | 25,000 | 0 | 0 | 0 | - | - | - | - |
Loans receivable advanced | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Cash of subsidiary disposed | ||||||||||||||
- | - | - | - | - | - | - | 11,000 | 11,000 | 11,000 | 11,000 | 0 | 0 | 0 | 0 |
Change in restricted cash | ||||||||||||||
-21,000 | 9,000 | -15,000 | 3,000 | 28,000 | 4,000 | 42,000 | 19,000 | 20,000 | -8,000 | -30,000 | -25,000 | 0 | 0 | 0 |
Net cash generated/(used) by financing activities | ||||||||||||||
- | 0 | 0 | - | - | -365,000 | -238,000 | -319,000 | -939,000 | 509,000 | 441,000 | 230,000 | 0 | 0 | 0 |
Repayments of debt | ||||||||||||||
0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - |
Repayments of debt | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Issuance of stock | ||||||||||||||
- | - | - | - | - | - | - | 10,000 | 8,000 | 795,000 | 799,000 | 798,000 | 0 | 0 | 0 |
Proceeds from debt | ||||||||||||||
0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Debt issue costs | ||||||||||||||
35,000 | 27,000 | 27,000 | 30,000 | 29,000 | 8,000 | 8,000 | 0 | 0 | 0 | 0 | - | - | - | - |
Net proceeds from debt | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Cash (outflows)/inflows from derivatives with financing | ||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Dividends paid to common stockholders | ||||||||||||||
62,000 | 108,000 | 134,000 | 215,000 | 235,000 | 235,000 | 189,000 | 131,000 | 89,000 | 75,000 | 75,000 | 67,000 | 0 | 0 | 0 |
Dividends paid to noncontrolling interests | ||||||||||||||
10,000 | 18,000 | 27,000 | 21,000 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Net increase/(decrease) in cash and cash equivalents | ||||||||||||||
-332,000 | -568,000 | -499,000 | -215,000 | 44,000 | 241,000 | 670,000 | 628,000 | -213,000 | -140,000 | -212,000 | -619,000 | 0 | 0 | 0 |
Effect of exchange rate changes on cash | ||||||||||||||
-30,000 | -35,000 | -37,000 | -5,000 | 4,000 | -93,000 | -73,000 | -102,000 | -50,000 | 113,000 | 98,000 | 105,000 | 0 | 0 | 0 |